Four dozen Boston startups were flush with new cash last month.
The most notable rounds? Inari Agriculture‘s $89 million Series C round, Cybereason‘s $200 million from Softbank, Ziopharm Oncology‘s $105 million securities sale and Algo Capital’s new $200 million Algo VC Fund.
Boston-based venture capital firm Vida Ventures also officially became the area’s latest biotech megafund, closing its second fund at $600 million. Vida II will be used to further the firm’s life sciences platform. With the close of Vida II, Vida has approximately $1 billion under management in less than two years since inception, the firm said.
FYI, we cover startup funding news in the BostInno Beat newsletter every weekday. Stay on top of who’s getting funded by signing up right here. See you in the inbox.
Below are the startups and VC firms that raised capital in August:Read Complete Article